Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-23

Clinical Trial Update: Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a radiofrequency probe for managing unresectable bile duct and pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ochsner Health System | Conditions: Pancreatic Cancer | Phase 1 | Status: UNKNOWN